vimarsana.com

Latest Breaking News On - கூறு உற்பத்தி - Page 3 : vimarsana.com

Telecom equipment makers soar after Govt extends PLI scheme to telecom sector

Shares of eight telecom equipment makers jumped by 2% to 17% after the Union Cabinet on 17 February 2020 extended the Production Linked Incentive (PLI) scheme for telecom and networking products.D-Link (India) (up 17.34%), ITI (up 10.3%), HFCL (up 10.2%), Tejas Networks (up 10%), Smartlink Holdings (up 9.55%), Optiemus Infracom (up 4.97%), Indus Towers (up 3.99%) and Avantel (up 2.09%) advanced. The approval comes in wake of PLI related to Mobile and component manufacturing, which was announced in April 2020 during the height of Covid pandemic. The scheme outlay is Rs 12,195 crore over five years. The eligibility for the scheme will be subject to achievement of a minimum threshold of cumulative incremental investment and incremental sales of manufactured goods net of taxes. Financial Year 2019-20 will be treated as the base year for computation of cumulative incremental sales of manufactured goods net of taxes. The scheme will be operational from 1 April 2021.

Robotic Flexible Washer Market | Latest Trends and Opportunities Analysis Report – KSU

Robotic Flexible Washer Market | Latest Trends and Opportunities Analysis Report – KSU
ksusentinel.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ksusentinel.com Daily Mail and Mail on Sunday newspapers.

Global ADC (Antibody Drug Conjugates) Contract Manufacturing Markets, 2020-2030: Current Scenario and Future Potential & Capabilities of Contract Services Providers

Share this article Share this article ResearchAndMarkets.com s offering. The report offers a comprehensive study of the current scenario and future potential of the ADC contract manufacturing market. The study features an in-depth analysis, highlighting the capabilities of contract services providers engaged in this domain. Overview Since the success of ADCETRIS (approved in 2011), antibody drug conjugates (ADCs) are now considered a versatile therapeutic tool and have been accepted into the contemporary portfolio of mainstream healthcare solutions. Over time, clinical researchers have been able to further their understanding of the intricacies of ADC design and have also improved the development process of these complex pharmacological interventions.

Semiconductor and Other Electronic Component Manufacturing Industry | Discover, Track, Compare, Evaluate Companies on BizVibe

Semiconductor and Other Electronic Component Manufacturing Industry | Discover, Track, Compare, Evaluate Companies on BizVibe This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201216005376/en/ Snapshot of BizVibe s semiconductor and other electronic component manufacturing industry group and product categories. (Graphic: Business Wire) Discover 10,000+ semiconductor and other electronic component manufacturing company profiles on BizVibe. Browse unlimited company profiles for free Companies listed under semiconductor and other electronic component manufacturing are defined as being primarily engaged in manufacturing any of the following; bare printed circuit boards, semiconductors, capacitors, resistors, coils, transistors, other inductors, electronic connectors, printed circuit assemblies, and/or other electronic components. BizVibe s detailed company profile insights help users to discover, track, evaluate, and connect

ADC Contract Manufacturing Market, 2020-2030 - Press Release

ADC Contract Manufacturing Market, 2020-2030 New York, Dec. 11, 2020 (GLOBE NEWSWIRE) Reportlinker.com announces the release of the report ADC Contract Manufacturing Market, 2020-2030 - https://www.reportlinker.com/p03290025/?utm source=GNW Over time, clinical researchers have been able to further their understanding of the intricacies of ADC design and have also improved the development process of these complex pharmacological interventions. Some of the recently approved ADC therapeutics include BLENREP® (2020), TRODELVYTM (2020), PadcevTM (2019) and POLIVY® (2019). In addition, there are close to 250 unique ADC product candidates under development. Several big pharma players, including AstraZeneca, GlaxoSmithKline, Pfizer, Roche and Takeda, have also acquired stake in this market. Moreover, the fact that companies involved in the development of ADCs, have received over USD 5 billion in capital investments (since 2011), attests to the therapeutic potential and growing p

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.